Sacituzumab govitecan in Chinese patients with recurrent/metastatic cervical cancer: Results from the phase 2 EVER-132-003 basket study (NCT05119907).
Saved in:
| Title: | Sacituzumab govitecan in Chinese patients with recurrent/metastatic cervical cancer: Results from the phase 2 EVER-132-003 basket study (NCT05119907). |
|---|---|
| Authors: | An, Jusheng1 (AUTHOR), Li, Guiling1,2,3 (AUTHOR), Zhang, Yunyan4 (AUTHOR), Feng, Mei5 (AUTHOR), Kong, Weimin6 (AUTHOR), Jiang, Haiping7 (AUTHOR), Luo, Suxia8 (AUTHOR), Li, Wei9 (AUTHOR), Xu, Cong10 (AUTHOR), Han, Ling11 (AUTHOR), Chen, Yi10 (AUTHOR), Mocci, Simonetta12 (AUTHOR), Yan, Yilin10 (AUTHOR), Wu, Lingying1 (AUTHOR) wulingying@csco.org.cn |
| Source: | Gynecologic Oncology. Nov2025, Vol. 202, p33-40. 8p. |
| Database: | Academic Search Ultimate |
| ISSN: | 00908258 |
|---|---|
| DOI: | 10.1016/j.ygyno.2025.09.001 |
